XNASAKAN
Market cap2mUSD
Dec 23, Last price
1.64USD
1D
16.31%
1Q
47.75%
IPO
-99.96%
Name
Akanda Corp
Chart & Performance
Profile
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | |||||
Revenues | 2,160 -17.55% | 2,620 6,223.00% | 41 1,909.26% | ||
Cost of revenue | 7,928 | 20,498 | 6,566 | ||
Unusual Expense (Income) | |||||
NOPBT | (5,768) | (17,878) | (6,525) | ||
NOPBT Margin | |||||
Operating Taxes | (8,632) | 1,093 | |||
Tax Rate | |||||
NOPAT | (5,768) | (9,245) | (7,618) | ||
Net income | (32,275) -8,228.82% | 397 -104.30% | (9,224) 213.11% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 14,933 | 5,054 | |||
BB yield | -7.23% | ||||
Debt | |||||
Debt current | 1,502 | 1,151 | 7,588 | ||
Long-term debt | 2,632 | 3,080 | 4,398 | ||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | 4,051 | 3,254 | 8,490 | ||
Cash flow | |||||
Cash from operating activities | (1,501) | (11,469) | (6,557) | ||
CAPEX | (2) | (311) | (576) | ||
Cash from investing activities | 25 | (4,219) | (576) | ||
Cash from financing activities | 1,487 | 14,139 | 11,236 | ||
FCF | 6,337 | (13,320) | (7,655) | ||
Balance | |||||
Cash | 83 | 492 | 3,495 | ||
Long term investments | 484 | ||||
Excess cash | 845 | 3,493 | |||
Stockholders' equity | (3,829) | 26,900 | (2,201) | ||
Invested Capital | 3,999 | 29,955 | 9,567 | ||
ROIC | |||||
ROCE | |||||
EV | |||||
Common stock shares outstanding | 4,505 | 3,464 | 2,890 | ||
Price | 17.62 -70.44% | 59.60 | |||
Market cap | 79,374 -61.55% | 206,439 | |||
EV | 83,425 | 209,693 | |||
EBITDA | (1,484) | (14,114) | (6,216) | ||
EV/EBITDA | |||||
Interest | 256 | 115 | 1,093 | ||
Interest/NOPBT |